Consensus Cencora, Inc. Deutsche Boerse AG

Stocks

ABG

US03073E1055

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 04:15:53 01/10/26 am AEST			5-day change	1st Jan Change
267.80 ^EUR	+1.13%		-1.43%	-14.63%

25/09	Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026	CI
25/09	Cencora Elects Ryder Systems' Robert Sanchez to Board	MT

2b87d9180d1adaa1e0f7.85Sw0pTq27OIrjGqGMnA9U72s_el-aGhCM5EIQ3fnlA.sNvbg8OG6Mm_9nDbLbiEmwa90IPttpCQUaEib2CuqWfL2eanoYSp-sLxeA~66b8f7ab006803dcc803bcbd15c2a732

Analysts' recommendations: Cencora, Inc.

19/08	RBC Initiates Cencora at Sector Perform With $330 Price Target	MT
11/08	Wells Fargo Adjusts Price Target on Cencora to $395 From $331, Keeps Overweight Rating	MT
08/08	JPMorgan Adjusts Price Target on Cencora to $390 From $382	MT
07/08	Citigroup Adjusts Price Target on Cencora to $370 From $355	MT
07/08	Leerink Partners Adjusts Price Target on Cencora to $380 From $368	MT
07/08	Evercore ISI Adjusts Price Target on Cencora to $350 From $330	MT
07/08	Baird Adjusts Price Target on Cencora to $370 From $340	MT
07/08	UBS Adjusts Price Target on Cencora to $430 From $412, Maintains Buy Rating	MT
22/07	Baird Adjusts Price Target on Cencora to $340 From $337, Maintains Outperform Rating	MT
21/07	BofA Securities Adjusts Cencora Price Target to $310 From $285	MT
07/07	Evercore ISI Adjusts Price Target on Cencora to $330 From $300	MT
25/06	Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating	MT
24/06	BofA Adjusts Price Target on Cencora to $285 From $280	MT
10/06	Barclays Cuts Cencora Price Target to $350 From $425, Maintains Overweight Rating	MT
21/05	Baird Adjusts Price Target on Cencora to $337 From $339, Maintains Outperform Rating	MT
11/05	Wells Fargo Adjusts Price Target on Cencora to $331 From $429	MT
09/05	McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says	MT
08/05	Morgan Stanley Lowers Price Target on Cencora to $342 From $400, Keeps Overweight Rating	MT
08/05	UBS Adjusts Price Target on Cencora to $412 From $410, Maintains Buy Rating	MT
28/04	William Blair Initiates Cencora at Market Perform	MT
09/04	Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating	MT
19/03	Baird Adjusts Price Target on Cencora to $420 From $415, Maintains Outperform Rating	MT
02/03	Leerink Partners Adjusts Price Target on Cencora to $447 From $410, Maintains Outperform Rating	MT
14/02	Barclays Adjusts Cencora Price Target to $425 From $400, Maintains Overweight Rating	MT
10/02	Wells Fargo Adjusts Price Target on Cencora to $429 From $405, Maintains Overweight Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+19.13%
	MEDTRONIC PLC					+20.37%
	STRYKER CORPORATION					+31.94%
	ESSILORLUXOTTICA					+61.01%
	CENCORA, INC.					+20.04%
	BECTON, DICKINSON AND COMPANY					+7.53%
	HOYA CORPORATION					+30.03%
	IDEXX LABORATORIES, INC.					+31.47%
	DEXCOM, INC.					+9.05%
	Average					+25.62%
	Weighted average by Cap.					+26.08%